The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued a joint statement in response to the new research on aortic valve replacement in low-risk patients announced during the Transcatheter Cardiovascular Therapeutics Conference, TCT 2023, and recently published in The Annals of Thoracic Surgery.
Results of the SAFE-TAVI Clinical Study, addressing aortic stenosis, will be presented at the Transcatheter Cardiovascular Therapeutics Conference (TCT), TCT 2023, to be held October 23-26 in San Francisco, CA, according to OpSens, a Quebec-based medical device company.